Hims & Hers Review (2026)
Independently researched · scored on our public 4-criteria methodology
Summarize this page with
The lifestyle telehealth giant's GLP-1 program — compounded semaglutide and tirzepatide from $199/mo, via a polished app with one of the smoothest onboarding experiences in the category and nationwide delivery.
See our top-rated pick: Wellorithm →Short answer
Hims & Hers scores 6.1/10 (#33 of 38 clinics) — we rate it Best App Experience. We could not reconfirm Hims & Hers's price at our last check (2026-07-21) — treat the previously-recorded $199/mo as unconfirmed, not current.
Our verdict
Hims & Hers earns 6.1/10 and ranks #33 of 38online GLP-1 clinics we've scored. We rate it Best App Experience. The lifestyle telehealth giant's GLP-1 program — compounded semaglutide and tirzepatide from $199/mo, via a polished app with one of the smoothest onboarding experiences in the category and nationwide delivery.
Pricing details
We could not reconfirm Hims & Hers's price at our last check (2026-07-21) — treat the previously-recorded $199/mo as unconfirmed, not current.
Classified as “Total not verified” — see how we classify every clinic's price →
Is Hims & Hers legit?
What we checked before publishing this page.
- ✓ A U.S.-licensed clinician reviews your case before anything is prescribed
- ✓ Intake includes a real medical questionnaire, not a rubber stamp
- ✓ Named price on their own site ($199/mo), last confirmed 2026-07-21
- ✓ Ranked by the rubric on our editorial policy page — payout status never enters into it
Independently verified on Trustpilot: 2.9/5 from 9,153 reviews (checked 2026-08-30). 2,380 of those (26%) are from the last 12 months — a rating resting mostly on old reviews reads differently than one built on recent ones. Company-wide rating across all Hims & Hers services, not GLP-1-specific. See reviews →
FDA warning letters on file
Hims & Hers Health, Inc. dba Hims — MARCS-CMS 716567, issued 2025-09-09 (Center for Drug Evaluation and Research (CDER)).
FDA states it reviewed hims.com in August 2025 and cites on-site claims — "Same active ingredient as Ozempic and Wegovy", "Clinically proven ingredients" — for implying the compounded semaglutide sold is the same as the FDA-approved product. FDA states compounded drugs are not FDA-approved, making the claims false or misleading and the products misbranded under FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)].
Hims & Hers Health, Inc. dba Hers — MARCS-CMS 716825, issued 2025-09-09 (Center for Drug Evaluation and Research (CDER)).
Same-day companion letter to the one above, addressed to the same parent company's forhers.com site. FDA cites claims — "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy", "Clinically proven ingredients" — on the same grounds: implying FDA-approved-equivalence for a compounded, non-FDA-approved product, in violation of FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)].
This is an allegation in FDA's opening enforcement communication — not an adjudicated finding of wrongdoing. See the full picture across all 29 clinics we track →
Confirmed regulatory action on file
FTC, joined by California and Utah lawsuit against Hims & Hers Health, Inc. — filed 2026-07-29 (3:26-cv-7871 (N.D. Cal.)).
Shared consumers' sensitive health information with third-party advertising platforms owned by Meta and Snap — via customer lists and tracking technology recording on-site "Events" — despite privacy representations that this data would be protected. Also alleges Hims fails to clearly disclose that it charges consumers almost immediately after intake-form submission, and makes cancellation difficult.
Does not move Hims' transparency score further — already at the 4.0 floor from its two open FDA warning letters, shown above. Disclosed on its own because it is, on its face, a more directly on-point transparency finding than the FDA letters: sharing health data with ad platforms while claiming to protect it is squarely about trust, not a marketing-claims technicality. Same entity, same case already applied on our sister site trt-picks.com under its "hims-trt" listing.
A government enforcement action confirming or alleging deceptive billing, cancellation, or data-handling practices caps this provider's transparency score the same way an open FDA warning letter does — one cap regardless of how many actions are on file. See our editorial policy →
What the research says
Dr. Daniel J. Drucker (Lunenfeld-Tanenbaum Research Institute, University of Toronto — co-discoverer of GLP-1 biology) reviewed the expanding evidence base for GLP-1 medicines beyond weight loss, including cardiovascular and kidney-disease benefit, alongside open questions on long-term safety that still require more data.
“GLP-1-based therapies for diabetes, obesity and beyond,” Nature Reviews Drug Discovery / Nature Medicine, 2025. More on GLP-1 safety →
Sources: Trustpilot
Third-party records
What we found outside Hims & Hers's own site — BBB, its named pharmacy partner (or lack of one), and whether it publishes a real HIPAA notice.
Better Business Bureau
Not Rated · not BBB accredited (checked 2026-08-30)
Dismissed: "Hims Inc dba Selvas BLV", Austin, TX — a retail optical-goods business, unrelated name coincidence only.
Same entity already named on the open FDA warning letters and the FTC lawsuit disclosed on this review. A second, separate BBB filing — "Hims & Hers Inc.", San Francisco, CA, also "Not Rated" — appears to be a related corporate filing, not confirmed as a duplicate.
Pharmacy partner
Inconclusive — hims.com is fully blocked, both via curl and WebFetch. Cannot confirm whether a pharmacy is named or not.
HIPAA disclosure
Inconclusive — hims.com returns HTTP 403 on every page. Cannot confirm presence or absence of a HIPAA notice.
Choose Hims & Hers if
- + You want best app experience
- + You're looking for compounded semaglutide
- + You're looking for compounded tirzepatide
Skip Hims & Hers if
- − Transparency & Trust scores lower (4.0/10)
- − Price & Value scores lower (7.0/10)
- − Clinical Oversight scores lower (8.0/10)
Hims & Hers pros & cons
What we like
- + Largest consumer telehealth brand with FDA-registered compounding pharmacy
- + Semaglutide and tirzepatide in injection and oral/sublingual formats
- + Sleek app, fast intake, discreet delivery nationwide
What could be better
- − Transparency & Trust scores lower (4.0/10)
- − Price & Value scores lower (7.0/10)
- − Clinical Oversight scores lower (8.0/10)
Quick facts
| Our score | 6.1/10 |
| Starting price | $199/mo |
| Treatment types | compounded semaglutide, compounded tirzepatide, oral / sublingual |
| Availability | All 50 states + DC |
| Insurance | Typically cash-pay (HSA/FSA often eligible) |
| Overall rank | #33 of 38 |
| Price status | Last confirmed 2026-07-21 |
Score breakdown
Sources: Full scoring methodology
How Hims & Hers works
- 1. Online intake. Complete a medical questionnaire and eligibility check (often BMI-based) covering your health history.
- 2. Clinician review. A licensed clinician reviews your information and, if appropriate, prescribes semaglutide or tirzepatide with a dose-titration plan.
- 3. Delivery & monitoring. Your medication ships discreetly to your door, with check-ins and dose adjustments along the way.
Frequently asked questions
How much does Hims & Hers cost?
Hims & Hers starts at $199/mo (last confirmed 2026-07-21). Final cost depends on your medication and dose.
Does Hims & Hers take insurance?
Like most online GLP-1 clinics, Hims & Hers generally operates cash-pay, though HSA/FSA funds are often eligible. Confirm directly at checkout.
How do I qualify for online GLP-1 treatment?
You complete a medical questionnaire and eligibility check (often BMI-based). A licensed clinician reviews it and, if appropriate, prescribes semaglutide or tirzepatide — there's no questionnaire-only prescription without clinician review.
Is Hims & Hers available in my state?
Hims & Hers is available in All 50 states + DC. Telehealth availability and shipping can vary by state.
Alternatives to Hims & Hers
Helpful tools
Compare Hims & Hers vs other clinics
Want a clinic you can sign up for today?
Our top-rated partner is Wellorithm — 8.3/10 · from $147/mo
Visit Wellorithm →Top picks
Price status: Last confirmed 2026-07-21.Scores are derived from our documented methodology and are never influenced by affiliate commissions. “Visit” links may be affiliate links that support our work. Educational information only — not medical advice.